Blood pressure pill showdown cancelled before it began
NCT ID NCT02483936
First seen Dec 12, 2025 · Last updated Apr 24, 2026 · Updated 18 times
Summary
This study was designed to compare two different combinations of blood pressure medications (olmesartan plus chlorthalidone vs. a marketed drug) in people with high blood pressure. The goal was to see if the new combination worked as well and was safe. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.